Connection

Scott Weaver to Antibodies, Viral

Back to Details
This is a "connection" page, showing publications Scott Weaver has written about Antibodies, Viral.
Scott Weaver
Connection Strength
0.233
Antibodies, Viral
  1. Molecular Virologic and Clinical Characteristics of a Chikungunya Fever Outbreak in La Romana, Dominican Republic, 2014. PLoS Negl Trop Dis. 2016 12; 10(12):e0005189.
    View in: PubMed
    Score: 0.066
  2. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants. Nature. 2021 08; 596(7871):273-275.
    View in: PubMed
    Score: 0.023
  3. IMMUNO-COV v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody Titers. mSphere. 2021 06 30; 6(3):e0017021.
    View in: PubMed
    Score: 0.022
  4. Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates. J Infect Dis. 2019 07 31; 220(5):735-742.
    View in: PubMed
    Score: 0.020
  5. Neutralizing Antibodies Inhibit Chikungunya Virus Budding at the Plasma Membrane. Cell Host Microbe. 2018 09 12; 24(3):417-428.e5.
    View in: PubMed
    Score: 0.019
  6. Enzootic Circulation of Chikungunya Virus in East Africa: Serological Evidence in Non-human Kenyan Primates. Am J Trop Med Hyg. 2017 Nov; 97(5):1399-1404.
    View in: PubMed
    Score: 0.017
  7. Serologic Evidence of Various Arboviruses Detected in White-Tailed Deer (Odocoileus virginianus) in the United States. Am J Trop Med Hyg. 2017 Aug; 97(2):319-323.
    View in: PubMed
    Score: 0.017
  8. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge. J Virol. 2017 04 15; 91(8).
    View in: PubMed
    Score: 0.017
  9. BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants. N Engl J Med. 2021 07 29; 385(5):472-474.
    View in: PubMed
    Score: 0.006
  10. Neutralizing Activity of BNT162b2-Elicited Serum. N Engl J Med. 2021 04 15; 384(15):1466-1468.
    View in: PubMed
    Score: 0.006
  11. An adjuvanted adenovirus 5-based vaccine elicits neutralizing antibodies and protects mice against chikungunya virus-induced footpad swelling. Vaccine. 2019 05 27; 37(24):3146-3150.
    View in: PubMed
    Score: 0.005
  12. A recombinant virus vaccine that protects against both Chikungunya and Zika virus infections. Vaccine. 2018 06 22; 36(27):3894-3900.
    View in: PubMed
    Score: 0.005
  13. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge. J Virol. 2018 02 15; 92(4).
    View in: PubMed
    Score: 0.004
  14. Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease. Cell. 2017 Jul 13; 170(2):273-283.e12.
    View in: PubMed
    Score: 0.004
  15. Emergence potential of sylvatic dengue virus type 4 in the urban transmission cycle is restrained by vaccination and homotypic immunity. Virology. 2013 Apr 25; 439(1):34-41.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.